Manuel Rodríguez-Pérez
About
In The Last Decade
Manuel Rodríguez-Pérez
20 papers receiving 270 citations
Peers
Comparison fields: 5 of 78
- Neurology 47
- Epidemiology 43
- Biomedical Engineering 42
- Molecular Biology 41
- Oncology 40
Countries citing papers authored by Manuel Rodríguez-Pérez
This map shows the geographic impact of Manuel Rodríguez-Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rodríguez-Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rodríguez-Pérez more than expected).
Fields of papers citing papers by Manuel Rodríguez-Pérez
This network shows the impact of papers produced by Manuel Rodríguez-Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rodríguez-Pérez. The network helps show where Manuel Rodríguez-Pérez may publish in the future.
Co-authorship network of co-authors of Manuel Rodríguez-Pérez
This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Rodríguez-Pérez. A scholar is included among the top collaborators of Manuel Rodríguez-Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Rodríguez-Pérez. Manuel Rodríguez-Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 10 | |
| 5 | 11 | |
| 6 | 3 | |
| 7 | Evaluation of a Novel P-glycoprotein Inducer Using [18F]MC225 and PET | 1 |
| 8 | 13 | |
| 9 | 36 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 9 | |
| 13 | 14 | |
| 14 | 22 | |
| 15 | 16 | |
| 16 | 9 | |
| 17 | 1 | |
| 18 | 4 | |
| 19 | Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis. | 44 |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.